Quality Controls in Ligand Binding Assays: Recommendations and Best Practices for Preparation, Qualification, Maintenance of Lot to Lot Consistency, and Prevention of Assay Drift

Overview

Journal AAPS J

Specialty Pharmacology

Date 2019 Jul 13

PMID 31297703

Citations 7

Authors

Mitra Azadeh

Perceval Sondag

Ying Wang

Maribeth Raines

Jeffrey Sailstad

Affiliations

Soon will be listed here.

Abstract

Quality controls (QCs) are the primary indices of assay performance and an important tool in assay lifecycle management. Inclusion of QCs in the testing process allows for the detection of system errors and ongoing assessment of the reliability of the assay. Changes in the performance of QCs are indicative of changes in the assay behavior caused by unintended alterations to reagents or to the operating conditions. The focus of this publication is management of QC life cycle. A consensus view of the ligand binding assay (LBA) community on the best practices for factors that are critical to QC life cycle management including QC preparation, qualification, and trending is presented here.

Citing Articles

Neutralizing Antibody Sample Testing and Report Harmonization.

Jani D, Gunsior M, Marsden R, Cowan K, Irvin S, Hay L AAPS J. 2024; 26(4):80.

PMID: 38992280 DOI: 10.1208/s12248-024-00955-1.

Development and performance of NLISA for C-reactive protein detection based on Prussian blue nanoparticle conjugates.

Nikitina M, Khramtsov P, Bochkova M, Rayev M Anal Bioanal Chem. 2024; 416(13):3097-3106.

PMID: 38635074 DOI: 10.1007/s00216-024-05268-y.

Overcoming Lot-to-Lot Variability in Protein Activity Using Epitope-Specific Calibration-Free Concentration Analysis.

Harvey I, Chilewski S, Bhosale D, Tobia S, Gray C, Gleason C Anal Chem. 2024; 96(16):6275-6281.

PMID: 38600735 PMC: 11044105. DOI: 10.1021/acs.analchem.3c05607.

Comprehensive performance evaluation of ligand-binding assay-LC-MS/MS method for co-dosed monoclonal anti-SARS-CoV-2 antibodies (AZD7442).

Huang Y, Woolf M, Wang C, Naser S, Wheeler A, Mylott Jr W Bioanalysis. 2024; 16(7):149-163.

PMID: 38385904 PMC: 11845114. DOI: 10.4155/bio-2023-0225.

Anti-drug Antibody Sample Testing and Reporting Harmonization.

Jani D, Marsden R, Gunsior M, Hay L, Ward B, Cowan K AAPS J. 2022; 24(6):113.

PMID: 36307592 DOI: 10.1208/s12248-022-00762-6.

References

Nowatzke W, Woolf E . Best practices during bioanalytical method validation for the characterization of assay reagents and the evaluation of analyte stability in assay standards, quality controls, and study samples. AAPS J. 2007; 9(2):E117-22. PMC: 2751400. DOI: 10.1208/aapsj0902013. View

Westgard J . Statistical quality control procedures. Clin Lab Med. 2013; 33(1):111-24. DOI: 10.1016/j.cll.2012.10.004. View

DeSilva B, Smith W, Weiner R, Kelley M, Smolec J, Lee B . Recommendations for the bioanalytical method validation of ligand-binding assays to support pharmacokinetic assessments of macromolecules. Pharm Res. 2003; 20(11):1885-900. DOI: 10.1023/b:pham.0000003390.51761.3d. View

Levey S, JENNINGS E . The use of control charts in the clinical laboratory. Am J Clin Pathol. 1950; 20(11):1059-66. DOI: 10.1093/ajcp/20.11_ts.1059. View

Shankar G, Devanarayan V, Amaravadi L, Barrett Y, Bowsher R, Finco-Kent D . Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products. J Pharm Biomed Anal. 2008; 48(5):1267-81. DOI: 10.1016/j.jpba.2008.09.020. View

Marcelletti J, Evans C, Saxena M, Lopez A . Calculations for Adjusting Endogenous Biomarker Levels During Analytical Recovery Assessments for Ligand-Binding Assay Bioanalytical Method Validation. AAPS J. 2015; 17(4):939-47. PMC: 4476982. DOI: 10.1208/s12248-015-9756-2. View

Azadeh M, Gorovits B, Kamerud J, MacMannis S, Safavi A, Sailstad J . Calibration Curves in Quantitative Ligand Binding Assays: Recommendations and Best Practices for Preparation, Design, and Editing of Calibration Curves. AAPS J. 2017; 20(1):22. DOI: 10.1208/s12248-017-0159-4. View

Viswanathan C, Bansal S, Booth B, DeStefano A, Rose M, Sailstad J . Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays. Pharm Res. 2007; 24(10):1962-73. DOI: 10.1007/s11095-007-9291-7. View

Azadeh M, Pan L, Qiu Y, Boado R . A Rapid Two-Step Iduronate-2-Sulfatatse Enzymatic Activity Assay for MPSII Pharmacokinetic Assessment. JIMD Rep. 2017; 38:89-95. PMC: 5874215. DOI: 10.1007/8904_2017_34. View

10.

Ray N, Hall D, Carver J . Deamidation of N76 in human γS-crystallin promotes dimer formation. Biochim Biophys Acta. 2015; 1860(1 Pt B):315-24. DOI: 10.1016/j.bbagen.2015.08.015. View

11.

Kelley M, Beaver C, Stevenson L, Bamford R, Gegwich P, Katsuhiko Y . Large molecule run acceptance: Recommendation for best practices and harmonization from the Global Bioanalysis Consortium Harmonization Team. AAPS J. 2014; 16(2):221-5. PMC: 3933574. DOI: 10.1208/s12248-013-9553-8. View